CD274 and neoplasm: Apart from mutation or neo-antigen load, multiple factors could affect immune checkpoint inhibitors’ effectiveness, such as PD-L1 level, degree of cytotoxic T cell infiltration, antigen presentation defects, interferon signaling, mismatch repair deficiency, tumor aneuploidy, intestinal microbiota, and so on.